9 Meters Biopharma Q2 FY20: net loss $44.6M; diluted EPS −$11.40

Key figures from this report

These are the numbers 9 Meters Biopharma reported for Q2 FY20, the quarter ended Jun 30, 2020, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

1. Net income−$44.6MNo year-earlier figure tagged10-Q income statement, on EDGAR
2. Diluted EPS−$11.40No year-earlier figure tagged. Split-adjusted, as the tables show it; the filing reported −$0.5710-Q income statement, on EDGAR
3. Cash and cash equivalents$13.5MNo year-earlier figure tagged10-Q balance sheet, on EDGAR
4. Cash from operations−$6.2MNo year-earlier figure tagged10-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters